April 1st, 2022 – Miranda Wallace
2022-04-01 – Miranda Wallace (Dantas lab) – Engineered probiotics as carriers of
next-generation immune checkpoint inhibitor therapies
2022-04-01 – Miranda Wallace (Dantas lab) – Engineered probiotics as carriers of
next-generation immune checkpoint inhibitor therapies